Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 11 | 71456989 | intron variant | A/G | snv | 0.62 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 11 | 71456989 | intron variant | A/G | snv | 0.62 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.200 | 11 | 71454579 | intron variant | A/G | snv | 0.54 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 11 | 71510202 | intron variant | A/G;T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 11 | 71510202 | intron variant | A/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.160 | 11 | 71476633 | 3 prime UTR variant | C/T | snv | 0.53 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.160 | 11 | 71476633 | 3 prime UTR variant | C/T | snv | 0.53 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
11 | 71462208 | intron variant | C/T | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
11 | 71462208 | intron variant | C/T | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.882 | 0.080 | 11 | 71523061 | intron variant | G/A | snv | 0.24 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 11 | 71523061 | intron variant | G/A | snv | 0.24 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 11 | 71523061 | intron variant | G/A | snv | 0.24 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 11 | 71523061 | intron variant | G/A | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.080 | 11 | 71523061 | intron variant | G/A | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.851 | 0.120 | 11 | 71483513 | intron variant | G/A | snv | 0.21 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.120 | 11 | 71483513 | intron variant | G/A | snv | 0.21 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.120 | 11 | 71483513 | intron variant | G/A | snv | 0.21 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 11 | 71483513 | intron variant | G/A | snv | 0.21 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 11 | 71483513 | intron variant | G/A | snv | 0.21 |
|
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |